Military Implements Mandatory Testosterone Screening

The Pentagon has rolled out new clinical guidelines mandating testosterone deficiency screening for active-duty and reserve service members aged 30 and above. This change follows an announcement by Defense Secretary Pete Hegseth authorizing the program to ensure optimal testosterone levels in troops.

Hegseth emphasized that maintaining proper testosterone levels is crucial for the long-term health and performance of military personnel, both on deployment and in their civilian lives.

“Taking care of your long-term health means ensuring you remain strong, resilient and capable,” stated Hegseth. This perspective highlights the shift from focusing on gender pronouns to prioritizing physical strength through proper hormonal balance.

The guidelines specify mandatory testosterone blood tests for men over 30. Younger male service members will be tested if requested or if warning signs are identified by healthcare professionals. Men with low testosterone may be evaluated further and offered voluntary hormone replacement therapy if necessary.

Testosterone, a hormone increasing during puberty, is vital for developing muscle strength, body hair, and sperm production. Generally, testosterone levels begin to decline naturally after age 30.

Women are not required to undergo routine testosterone tests but will be screened for related hormonal issues, including fatigue and menstrual cycle disruptions, which may indicate underlying conditions.

Testosterone prescriptions for women are limited, with specific guidelines for off-label use, particularly in postmenopausal women experiencing low sexual desire. The military continues to prohibit testosterone use without a medical prescription, especially for non-medical enhancement purposes.

The Pentagon aims to enhance military readiness by identifying and managing issues related to hormonal balance and energy availability for both men and women through standardized screening and treatment pathways.

Some endocrinologists and medical experts have expressed concerns regarding the broad testing approach, suggesting it may lead to unnecessary treatments without significant evidence of improved military readiness. The Food and Drug Administration plans to hold a meeting to discuss the use of testosterone in medical settings.